ACSL3 and nonpapillary renal cell carcinoma: ACSL3 expression was substantially linked with clinical stage, OS, DFS, DNA methylation, and immune cell infiltration, suggesting that it may be a target for clinical diagnosis, prognosis, and therapy of patients with ccRCC.